Skip to main content

Table 1 Articles included in the scoping review

From: Efficacy of the use of perfluorocarbon as a temporary tamponade agent in severe ocular trauma and/or complex retinopexy: a scoping review

Author

Year

Study type

Retinal reattachment N (%)

Complications N (%)

Bhardwaj G. et al. [5]

2020

Case series

19 (100%)

cataract, PFC in anterior chamber, macular pucker (5%)

Maya Eiger-Moscovich et al. [6]

2017

Case series

13 (100%)

ocular hypertension 2 (15%), cataract 2 (15%), cystoid macular edema 2 (15%)

Joseph Pikkel et al. [7]

2013

Cohort study

22 (100%)

cataract 4 (13.6%) ocular hypertension 4 (13.6%) epiretinal membrane 2 (7%)

Marcelo Carvalho VenturaI et al. [8]

2007

Case series

8 (80%)

hipotonía ocular 3 (37.5%)

Rofail, Marc et al. [9]

2005

Case series

15 (93.7%)

cataract 5 (31.5%)

M Sirimaharaj et al. [10]

2005

Case series

58 (93.5%)

cataract 51 (80.5%)

Daminana Zeana et al. [11]

1999

Clinical Animal Experiment

Not evaluated as an outcome

peripheral atrophy of the myelinated nerve fibers (14,5%)

Luca Migliavacca et al. [12]

1998

Clinical Animal Experiment

Not evaluated as an outcome

pits on the inner retina ​​

Drury B, Bourke RD

2009

Case series

76%

superior redetachment, atrophic macular changes, minor macular haemorrhage, cataract, elevated intraocular pressure, corneal defects, PVR, epiretinal membrane and retained perfluorocarbon heavy liquid.

Chehade LK et al.

2021

Case series

98.8%

Cataract formation

Bottoni, F et al.

2013

Case series

9 (82%)

Macular pucker 1 (9%)

Rush R, et al.

2012

Case series

39 (100%)

Capsular opacification 28 (71%)